New pages
Jump to navigation
Jump to search
- 13:26, 26 March 2024 Glycoprotein non-metastatic B (hist | edit) [1,086 bytes] Michael (talk | contribs) (Created page with "'''Glycoprotein non-metastatic B''', abbreviated '''GPNMB''', is an immunostain. It is typically positive in TSC1/TSC2/MTOR mutated renal cell carcinomas.<ref name=pmid37...")
- 12:44, 26 March 2024 Perinephric myxoid pseudotumour of fat (hist | edit) [834 bytes] Michael (talk | contribs) (Created page with "'''Perinephric myxoid pseudotumour of fat''', abbreviated '''PMPF''', is a rare lesion found around the kidney.<ref>{{cite journal |authors=Dashti NK, Fritchie KJ, Folpe A...")
- 23:53, 25 March 2024 Gastrointestinal bleeding (hist | edit) [249 bytes] Michael (talk | contribs) (Created page with "'''Gastrointestinal bleeding''', also '''gastrointestinal bleed''', is bleeding from the gastrointestinal tract. It is generally divided into: *Lower GI bleed. *Upper G...")
- 04:04, 20 March 2024 Renal neoplasms with TSC/mTOR pathway mutations (hist | edit) [1,660 bytes] Michael (talk | contribs) (create) originally created as "Renal neoplasms with TSC/mTOR mutations"
- 00:30, 20 March 2024 Renal cell carcinoma with fibromyomatous stroma (hist | edit) [3,010 bytes] Michael (talk | contribs) (create)
- 16:17, 8 March 2024 Fibroblast growth factor receptors (hist | edit) [1,170 bytes] Michael (talk | contribs) (create)
- 16:06, 23 February 2024 Dihydropyrimidine dehydrogenase deficiency (hist | edit) [614 bytes] Michael (talk | contribs) (create)
- 19:35, 21 February 2024 Lung cancer after neoadjuvant therapy (hist | edit) [2,094 bytes] Michael (talk | contribs) (create)
- 16:25, 22 January 2024 Clear cells in the kidney (hist | edit) [2,196 bytes] Michael (talk | contribs) (create)
- 17:14, 18 January 2024 Intimal sarcoma (hist | edit) [897 bytes] Michael (talk | contribs) (create)